By G HossainPosted on October 24, 2025Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs The discontinued CAR T therapy bbT369 came to Regeneron when the pharma bought all of 2seventy bio’s pipeline assets for $5 million upfront in January 2024. Regeneron Cans 2seventy-Acquired CAR T Candidate for Lymphoma in ‘Strategic’ Move Post navigation Sanofi’s Legacy Vaccine Sales Decline As Americans Skip Flu Shots$17M in Tax Incentives Will Add 800 Life Sciences Jobs This Year in Massachusetts